FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for CANCIDAS (caspofungin acetate) filed by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis
• Invasive Fungal Infections

Drugs mentioned

• Cancidas (caspofungin)

Snippet

SUPPL AP for CANCIDAS (CASPOFUNGIN ACETATE)